Positron Emission Tomography Market Size

The positron emission tomography market size was valued at around USD 2.1 billion in 2024 and is estimated to grow at 6.1% CAGR from 2025 to 2034. Positron Emission Tomography (PET) is an advanced imaging technique used in medicine to observe metabolic and physiological processes within the body. It provides detailed functional images that aid in diagnosing, monitoring, and managing various diseases.

The PET market is experiencing significant technological advancements through the development of hybrid imaging systems that combine PET with CT or MRI technology. These integrated systems offer improved diagnostic accuracy and are in high demand. For example, in July 2021, GE Healthcare collaborated with Quibim to develop an innovative total-body PET/CT scanner for simultaneous whole-body imaging. This product development strengthens the company’s market position and expands its product offerings, thus driving industry growth.

Technological advancements are broadening PET applications in clinical practice. PET imaging’s role in disease diagnosis and treatment continues to evolve with advancing technology. For instance, time-of-flight PET technology improves image resolution and shortens scan times by calculating photon travel time between the source and detector, enabling faster production of high-quality images. These technological innovations are expected to drive market growth.

Moreover, the growing demand for PET analysis in radiopharmaceuticals is being fueled by several factors, including the rising prevalence of cancer, the increased availability and affordability of PET scanners, and the expanding range of applications for PET in the diagnosis and monitoring of various medical conditions. Additionally, the development of new radioisotopes and radiotracers has further expanded the scope of PET analysis. As a result, these factors are expected to contribute to the continued growth of the market.

Positron Emission Tomography Market Trends

The integration of PET with CT scanning technology continues to gain prominence in diagnostic imaging. Healthcare facilities are increasingly adopting these hybrid systems because they provide both anatomical and functional information in a single examination, improving diagnostic accuracy and treatment planning.

• The use of PET imaging in cardiac diagnostics is expanding, especially for myocardial perfusion imaging and viability assessment. This growth is driven by PET's superior diagnostic accuracy compared to traditional nuclear imaging methods.
  
• The development of novel radiopharmaceuticals, particularly those targeting specific diseases and conditions, is enhancing PET imaging capabilities. New tracers for neurological disorders, oncology, and cardiac conditions are broadening the application of PET technology.
  
• Healthcare facilities are transitioning from analog to digital PET detectors. Digital PET systems offer improved image quality, reduced scanning time, and lower radiation exposure, driving their adoption in clinical settings.
  
• AI algorithms are being integrated into PET imaging workflows for image reconstruction, analysis, and interpretation. These technologies help improve image quality, reduce scan times, and assist in more accurate diagnoses.
  
• The emergence of mobile PET imaging services is addressing accessibility issues in remote and rural areas. These services enable healthcare providers to extend advanced diagnostic capabilities to underserved populations.
  
• Manufacturers are developing new technologies and protocols to minimize radiation exposure during PET scans. This trend aligns with the growing emphasis on patient safety and regulatory requirements for radiation dose management.
  
• PET imaging continues to find new applications in cancer diagnosis, staging, and treatment monitoring. This technology is particularly valuable in detecting early-stage cancers and evaluating treatment responses.
  

Positron Emission Tomography Market Analysis

Learn more about the key segments shaping this market

Download Free Sample

Based on product type, the market is categorized into partial ring PET scanner and full ring PET scanner. The full ring PET scanner segment led the market with a revenue of USD 1.7 billion in 2024 and is expected to grow at a significant CAGR during the forecast period.

• Full ring PET scanners demonstrate effectiveness across various clinical applications, including oncology, cardiology, neurology, and psychiatry, expanding the patient population that can benefit from PET imaging.
  
• The market growth for full ring PET scanners is further driven by the rising cancer incidence, technological advancements in PET systems, increased demand for personalized medicine, an aging population, and greater awareness of PET imaging capabilities. For instance, the American Cancer Society estimates that there will be nearly 2 million new cancer cases in the U.S. in 2024.
  
• These factors are expected to drive the growth of the overall market during the forecast period.
  

Based on detector type, the positron emission tomography market is segmented into lutetium oxyorthosilicate (LSO), silicon photomultiplier (SiPM), lutetium yttrium orthosilicate (LYSO), digital photon counters (DPC) and other detector types. The lutetium oxyorthosilicate (LSO) detector type segment led the market with a revenue of USD 725.1 million in 2024 and is expected to grow at a significant CAGR during the forecast period.

• LSO PET scanners have become increasingly popular due to their high sensitivity, improved spatial resolution, and ability to acquire images faster than previous-generation PET scanners.
  
• LSO crystals are known for their high sensitivity and fast light decay time, enabling accurate detection of gamma photons and faster imaging processes. This makes LSO PET scanners particularly attractive in oncology, neurology, and cardiology, where detailed and timely diagnostic imaging is crucial.
  
• Additionally, advancements in hybrid imaging systems, such as PET/CT and PET/MRI, have bolstered the adoption of LSO detectors due to their compatibility and enhanced performance in these modalities. Governments and private organizations are also investing in upgrading healthcare infrastructure, especially in developing regions, to incorporate state-of-the-art imaging systems like LSO PET.
  
• Thus, the increasing popularity of LSO detectors will drive segmental growth in the future.
  

Learn more about the key segments shaping this market

Download Free Sample

Based on end use, the positron emission tomography market is segmented into hospitals, diagnostic centers, ambulatory surgical centers, and other end users. The hospitals segment dominated the market in 2024 and is expected to grow significantly to reach USD 1.4 billion by 2034.

• Hospitals are increasingly adopting PET technology to address the rising prevalence of chronic conditions such as cancer, neurological disorders, and cardiovascular diseases. PET imaging plays a critical role in early detection and personalized treatment planning, aligning with the healthcare industry's shift towards precision medicine.
  
• Its integration with hybrid imaging modalities, like PET/CT and PET/MRI, further enhances diagnostic capabilities, making it an essential tool in modern hospital settings.
  
• Another key factor is the expansion of healthcare infrastructure and government investments in advanced diagnostic technologies, particularly in emerging markets. Hospitals are upgrading their imaging facilities to meet growing patient demand for accurate and non-invasive diagnostic tools. Additionally, advancements in PET technology, such as time-of-flight (TOF) and LSO detectors, have improved image quality, reduced scan times, and enhanced patient comfort, further accelerating hospital adoption.
  

Looking for region specific data?

Download Free Sample

In 2024, the U.S. led the North American positron emission tomography market, generating USD 713.8 million, and is expected to see significant growth during the forecast period.

• The increasing prevalence of cancer and cardiovascular diseases in the U.S. is driving the growth of the market. According to the Centers for Disease Control and Prevention, approximately 680,909 people died from heart disease in the U.S. in 2023. This rising disease burden, combined with an aging population more susceptible to chronic conditions, has increased the demand for accurate diagnostic imaging technologies like PET scanners.
  
• Technological advancements in PET imaging systems, including improved image resolution and reduced scanning times, are contributing to market expansion. The integration of artificial intelligence and machine learning in PET imaging has enhanced diagnostic accuracy and workflow efficiency. Additionally, favorable reimbursement policies for PET procedures and increasing investments in healthcare infrastructure are supporting market growth in the U.S.
  

From 2025 to 2034, France's market is expected to grow significantly.

• France’s robust healthcare infrastructure and favorable reimbursement policies support the growth of the PET market. The country’s commitment to technological advancement in medical imaging, combined with increasing investments in healthcare facilities and research institutions, enhances the adoption of PET systems.
  
• Additionally, the expanding applications of PET imaging beyond oncology, including neurology and cardiology, are contributing to market expansion.
  
• These factors are expected to drive the growth of France’s market during the forecast period.
  

Between 2025 and 2034, the Asia Pacific positron emission tomography market is anticipated to grow significantly.

• The growing aging population, particularly in countries like Japan and China, has led to a higher incidence of chronic diseases that require advanced diagnostic imaging. Additionally, rising healthcare expenditure and improving healthcare infrastructure across developing economies are supporting the adoption of PET scanning technologies in the region.
  
• Moreover, technological advancements in PET imaging systems, coupled with increasing investments in healthcare facilities, are further propelling market growth. Government initiatives to improve cancer diagnosis and treatment facilities, along with the expansion of nuclear medicine in hospitals across countries such as India, South Korea, and Australia, are contributing to market expansion.
  

From 2025 - 2034, South Africa's positron emission tomography market is expected to grow significantly.

• The South African positron emission tomography (PET) market is experiencing significant growth due to increasing collaborations between medical device manufacturers and healthcare providers.
  
• Market expansion is also supported by the growing focus on research and development activities in molecular imaging. The increasing number of clinical trials utilizing PET imaging technology, coupled with rising medical tourism in South Africa, is creating new opportunities for market growth.
  

Positron Emission Tomography Market Share

The market features established companies such as Siemens Healthineers, GE Healthcare, Koninklijke Philips, and Canon Medical Systems Corporation as key players. These companies focus on technological advancements, strategic partnerships, and geographical expansion to maintain their market positions. The competitive landscape is characterized by significant investments in research and development to enhance imaging quality, reduce radiation exposure, and improve diagnostic accuracy. Market players are also expanding their product portfolios through mergers and acquisitions, while simultaneously developing integrated solutions that combine PET with other imaging modalities like CT and MRI. Regional expansion, particularly in emerging markets, and the development of cost-effective systems remain primary competitive strategies.

Positron Emission Tomography Market Companies

Some of the eminent market participants operating in the positron emission tomography industry include:

• Canon Medical Systems Corporation
• CMR Naviscan
• Fujifilm Holdings Corporation
• GE Healthcare
• Koninklijke Philips
• Mediso
• Minfound Medical Systems
• Molecubes
• Neusoft Corporation
• Oncovision
• Positron
• Radialis
• Siemens Healthineers
• Toshiba International Corporation
• Yangzhou Kindsway Biotech   
  

Positron Emission Tomography Industry News:

• In November 2024, Positron partnered with Upbeat Cardiology Solutions in order to expand its cardiac PET-CT offerings. The strategy aimed at utilizing company’s NeuSight PET-CT 64 slice scanner to offer highest level of imaging care to the patients. Thus, gaining competitive advantage.
  

The positron emission tomography market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and volume in terms of units from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Partial ring PET scanner
• Full ring PET scanner

Market, By Detector Type

• Lutetium oxyorthosilicate (LSO)
• Silicon photomultiplier (SiPM)
• Lutetium yttrium orthosilicate (LYSO)
• Digital photon counters (DPC)      
• Other detector types

Market, By End Use

• Hospitals
• Diagnostic centers
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe 
  • Germany
  • UK
  • France          
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America 
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE